
CLSDQ
Healthcare · Biotechnology · $1.3M market cap
Latest report
After the close
The next earnings date isn’t on the calendar yet.
Analyst consensus
Analyst estimates aren’t available for this symbol.
Beat estimates in 2 of the last 4 reported quarters.
EPS surprise versus the estimate at the time of the report.
| Date | Session | Estimate | Actual | Surprise |
|---|---|---|---|---|
| Nov 14, 2025 | After the close | -0.60 | -1.14 | -90.0% |
| Aug 8, 2025 | After the close | -1.52 | -0.06 | +96.1% |
| May 14, 2025 | After the close | -1.60 | -1.65 | -3.1% |
| Mar 28, 2025 | Time not confirmed | -1.55 | -1.50 | +3.2% |
| Nov 12, 2024 | After the close | -1.86 | -1.50 | +19.4% |
| Aug 12, 2024 | After the close | -2.02 | -1.50 | +25.7% |
| May 10, 2024 | After the close | -2.14 | -2.55 | -19.2% |
| Mar 13, 2024 | Time not confirmed | — | -1.16 | — |
| Nov 13, 2023 | After the close | -2.29 | -2.25 | +1.7% |
| Aug 14, 2023 | After the close | -2.17 | -2.25 | -3.7% |
| May 12, 2023 | After the close | -2.10 | -2.25 | -7.1% |
| Mar 10, 2023 | Time not confirmed | — | -2.40 | — |
| Nov 9, 2022 | Before the open | -2.15 | -1.95 |
Clearside Biomedical, Inc., a biopharmaceutical company, focuses on the revolutionizing the delivery of therapies to the back of the eye through the suprachoroidal space. The company offers XIPERE, a triamcinolone acetonide injectable suspension for the treatment of macular edema associated with uveitis. It also develops CLS-AX, an axitinib injectable suspension for suprachoroidal injection, which has completed…
| +9.3% |
| Aug 9, 2022 | Before the open | -2.02 | -1.95 | +3.5% |
| May 11, 2022 | After the close | -1.75 | -1.95 | -11.4% |
| Mar 11, 2022 | Time not confirmed | — | 4.59 | — |
| Nov 10, 2021 | After the close | -1.08 | -1.20 | -11.1% |
| Aug 10, 2021 | After the close | -1.92 | -1.65 | +14.1% |
| May 17, 2021 | After the close | -1.72 | -1.95 | -13.4% |
| Mar 11, 2021 | Time not confirmed | — | -2.17 | — |
| Nov 10, 2020 | After the close | -1.75 | -0.75 | +57.1% |
| Aug 10, 2020 | After the close | -1.10 | -1.95 | -77.3% |
| May 8, 2020 | After the close | -0.45 | -1.05 | -133.3% |
| Mar 12, 2020 | Time not confirmed | — | -1.10 | — |
| Nov 6, 2019 | After the close | -2.36 | -2.55 | -8.1% |
| Aug 7, 2019 | After the close | -5.89 | -3.32 | +43.6% |
| May 8, 2019 | Time not confirmed | — | -6.77 | — |
| Mar 12, 2019 | After the close | -8.49 | -10.20 | -20.1% |
| Nov 8, 2018 | After the close | -9.48 | -11.25 | -18.7% |
| Aug 8, 2018 | Before the open | -8.64 | -9.75 | -12.8% |
| May 9, 2018 | Before the open | -8.73 | -9.30 | -6.5% |
| Mar 14, 2018 | Time not confirmed | — | -9.76 | — |